Kenichi Furuya

7PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 04, 2018
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.

Kazuki Takasaki, Morikazu Miyamoto, Masashi Takano

|Feb 06, 2018
Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.

Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama

|Nov 24, 2017
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano

|Nov 11, 2017
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.

Morikazu Miyamoto, Masashi Takano, Mika Kuwahara

|May 31, 2017
Multiple placental surface cysts with intracystic hemorrhaging: A case report and review of the literature.

Hiroaki Soyama, Morikazu Miyamoto, Hidenori Sasa

|Apr 07, 2017
Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas.

Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama

Pageof 2

Frequent Collaborators

7 joint publications

Morikazu Miyamoto

7 joint publications

Masashi Takano

7 joint publications

Hiroaki Soyama

5 joint publications

Tadashi Aoyama